11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†-Reference-Cited by-同舟云学术

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†

Published:2001-12-31 Issue:4 Volume:33 Page:362-378
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Bloomfield Clara D.,Archer Kellie J.,Mrózek Krzysztof,Lillington Debra M.,Kaneko Yasuhiko,Head David R.,Dal Cin Paola,Raimondi Susana C.

Funder

National Cancer Institute

Leukemia Clinical Research Foundation

The American Lebanese Syrian Associated Charities (ALSAC)

St. Jude Children's Research Hospital

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference52 articles.

1. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation;Albain;Genes Chromosomes Cancer,1990

2. Acute myeloid leukemia with t(6;9)(p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype;Alsabeh;Am J Clin Pathol,1997

3. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements;Andersen;Haematologica,1998

5. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia;Bloomfield;Cancer,1997

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine;Frontiers in Oncology;2024-04-26

2. Leukemias, Lymphomas, and Plasma Cell Disorders;Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics;2023

3. Chromosome Abnormalities in Hematological Malignancies and Its Clinical Significance;Down Syndrome and Other Chromosome Abnormalities;2022-03-23

4. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML;Blood Advances;2022-01-08

5. Diagnostic Applications of Nuclear Medicine: Leukemias;Nuclear Oncology;2022